Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22)

Tomoko Nanri,N Matsuno,Toshiro Kawakita,Hitoshi Suzushima,Fumio Kawano,Hiroaki Mitsuya,Norio Asou

Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22)

2005

Tomoko Nanri
N Matsuno
Toshiro Kawakita
Hitoshi Suzushima
Fumio Kawano
Hiroaki Mitsuya
Norio Asou

Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22)

Keywords:

Acute myeloblastic leukemia
Cancer research
Genetics
Core binding factor acute myeloid leukemia
Hematology
T(8;21)(q22;q22)
Receptor tyrosine kinase
Fms-Like Tyrosine Kinase 3
Acute leukemia
Immunology
Mutation
Internal medicine
Biology
Exon
Tyrosine kinase

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations